Sterling Winthrop (sanofi)
Prior to Churchill, Ben was Vice President of Reimbursement and Patient Access for GlaxoSmithKline and also Vice President of Policy and Payer Insight for Oncology/Biopharmaceuticals within GSK’s US market access division. Ben led Global Marketing for oncology and was accountable for global product management, scientific communications and health outcomes for GSK’s oncology portfolio. Product responsibilities have included multiple therapeutic and supportive care products, as well as many discovery and development stage products.
Before joining GSK, he worked in senior roles at Exocell, a development-stage biotechnology company, and Eastman Pharmaceuticals/Sterling Winthrop (now Sanofi).